Monday, May 20, 2013

Candice Glover to Release Album in July

Source: http://www.thehollywoodgossip.com/2013/05/candice-glover-to-release-album-in-july/

allure jane goodall saturday night fever glamping forgetting sarah marshall taraji p. henson shuttle discovery

Therapy at Work? Bosses Say Yes

Bosses who help their employees deal with emotional problems shouldn't expect much gratitude or loyalty for their efforts, new research shows.

A study in the current issue of the Academy of Management Journal finds that subordinates, who tend to seek help with personal and job concerns from supervisors rather than from co-workers, typically view a boss's help as part of their managerial responsibilities, while supervisors see them as good deeds that go well beyond their job duties.

The research revealed that the disparity extended to the expectation of reciprocity, with subordinates seeing little or no obligation to reciprocate for emotional help, whereas managers expected payback in the form of increased commitment and loyalty from the employee.

[11 Things That Make Workers Happy]

The study highlights the case of one manager who devoted a lot of time to helping a staff member deal with emotional troubles only to have her leave for another company just when she seemed to be turning the corner. When the manager showed disappointment, the subordinate was surprised, having had taken for granted that such help was part of a boss's job.

One of the study's authors, Ginka Toegel of the IMD business school in Lausanne, Switzerland, said although most managers don't show their disappointment as overtly as the one in the case study did, they do have clear expectations.

"They feel that helping with emotional problems is above and beyond their job responsibilities and expect employees to return the favor through enhanced recognition, loyalty and commitment," Toegel said. "In short, no second thoughts if there's a deadline to meet and the employee is asked to stay late."

Toegel said supervisors should have realistic expectations when dealing with employees and shouldn't be surprised that subordinates would consider it part of their boss's job to maintain a healthy emotional climate.

"The fact is that supervisors do benefit from a happy team in terms of productivity and results, as most of our interviewees were aware," Toegel said. "Emotional rewards beyond that would be nice, but their absence should not be an occasion for bitterness or hand-wringing."

The study?s message for employees should be that help from a supervisor comes with expectations for gratitude and personal loyalty, Toegel said.

"If employees are not comfortable with that, they should think twice about going to their supervisor for help or even accepting an offer for help," she said.

The study, based on an in-depth analysis of a recruiting agency specializing in providing managerial staff for retail outlets, was co-authored by Anand Narasimhan, of the IMD business school, and Martin Kilduff of University College London.

This story was provided by BusinessNewsDaily, a sister site to LiveScience. Follow Chad Brooks on Twitter @cbrooks76 or BusinessNewsDaily @BNDarticles. We're also on Facebook & Google+. This story was originally published on BusinessNewsDaily.

Copyright 2013 LiveScience, a TechMediaNetwork company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Source: http://news.yahoo.com/therapy-bosses-yes-104034268.html

brian urlacher Harry Reems ncaa basketball ncaa tournament schedule March Madness Live Google Keep ncaa scores

98% Mud

All Critics (131) | Top Critics (31) | Fresh (129) | Rotten (2)

There is an enchanted-fairy-tale aspect to Mud, but its bright, calm surface only barely disguises a strong, churning undercurrent.

A modern fairy tale, steeped in the sleepy Mississippi lore of Twain and similar American writers, and with a heart as big as the river is wide.

Nichols has a strong feeling for the tactility of natural elements-water, wood, terrain, weather.

Nichols takes his time with the story, dwelling on how the boy is shaped by the killer's tragic sense of romance, yet the suspense holds.

"Mud" isn't just a movie. It's the firm confirmation of a career.

"Mud" unfolds at its own pace, revealing its story in slivers. The performances are outstanding, especially from Sheridan, who plays tough, sweet, vulnerable and confused with equal conviction.

As Mud might say, it's a hell of a thing.

The boys are so skillfully played that Mud also plays like cinema verite. Nichols' fluid camerawork suggests a documentary-style approach. That helps these young lads transform into flesh-and-blood characters who get our attention and support.

Sheridan, who played the Terrence Malick surrogate in The Tree Of Life, is terrific at conveying adolescent confusion with tiny squints and frowns, and McConaughey plays off him masterfully.

Carefully crafting films that fly just below the political radar, director-writer Jeff Nichols is slowly, but surely, reweaving the fabric of the American dream.

It's totally worth it to pay good money to see a good, little film nestled between theaters showing 'Iron Man 3' and 'The Great Gatsby.' (Complete Content Details for Parents also available)

This is a junior adventure story echoing Huckleberry Finn and Stand By Me, a tale which is in no hurry to unfold, but beautifully done, exquisitely performed, and filled with terror and wonder.

Beautifully acted, intellectually engaging, and dramatically satisfying, Mud deserves to rocket to the top of your must-see list.

Nichols is a gifted writer-director who knows how to get into the heads of his characters. And this film has superior actors who create people who are intriguing and hugely involving.

'Mud' is a standout film in this 'coming of age' genre mainly because of its central character, one tough, warm-hearted, stubborn little kid who believes in the power of love, above all else.

Other than pacing problems that needlessly stretch the film past the two-hour mark, 'Mud' slings the dirt and sweat with the best of them, as it both mourns and celebrates a way of life that's all but disappeared.

A sublime coming-of-age film, 'Mud' would be the offspring if 'Stand By Me' and 'Cape Fear' reproduced.

Mud is a movie of striking performances and memorable images and of people who seem to belong in rather than being imposed upon their environment.

A brilliant metaphor for how a child deals with divorce.

This might be Mud. But it deserves to stick.

This is a film that gives McConaughey the chance to be an actor rather than a star, and, not for the first time, he grabs the opportunity.

Gone is the rom-com character and emphasis on a toothy smile and six-pack abs. Matthew McConaughey is showing off some acting chops.

Mud is, perhaps, a little longer than it needed to be, but few sensitive viewers will begrudge Nichols his indulgence. This director is the real thing.

Writer-director Nichols continues to get inside the heads of his characters with this involving but overlong dramatic thriller.

No quotes approved yet for Mud. Logged in users can submit quotes.

Source: http://www.rottentomatoes.com/m/mud_2012/

hillary clinton apple stock Pro Bowl 2013 Kick Ass Torrents jamarcus russell Sloane Stephens Beyonce Lip Sync

North Korea fires short-range missiles for two days in a row

By Jane Chung

SEOUL (Reuters) - North Korea fired a short-range missile from its east coast on Sunday, a day after launching three of these missiles, a South Korean news agency said, ignoring calls for restraint from Western powers.

Launches by the North of short-range missiles are not uncommon but, after recent warnings from the communist state of impending nuclear war, such actions have raised concerns about the region's security.

"North Korea fired a short-range missile as it did yesterday into its east sea in the afternoon, " South Korea's news agency Yonhap reported, citing a military official.

A South Korean defense ministry official confirmed the Yonhap report, but did not provide any details.

U.N. Secretary General Ban Ki-moon said he was concerned about North Korea's launch of short-range missiles, urging Pyonyang to refrain from further launches and return to stalled nuclear talks with world powers.

Ban, who spoke to Russian state news agency RIA Novosti during a visit to Moscow, called Saturday's launch a "provocative action".

Tension on the Korean peninsula has subsided in the past month, having run high for several weeks after the United Nations Security Council imposed tougher sanctions against Pyongyang following its third nuclear test in February.

The North had for weeks issued nearly daily warnings of impending nuclear war with the South and the United States.

South Korea's Unification Ministry criticized the missile tests as deplorable and urged the North to lower tensions and hold talks over a suspended inter-Korean industrial park in the North's border city of Kaesong.

South Korea pulled out all of its workers from the industrial zone early this month after North Korea withdrew its 53,000 workers as tensions mounted.

(Additional reporting by Alissa de Carbonnel in MOSCOW; Editing by Sanjeev Miglani)

Source: http://news.yahoo.com/north-korea-fires-short-range-missiles-two-days-101918143.html

once upon a time once upon a time RG3 Monsters University nfl playoff schedule Rex Ryan tattoo Alaska earthquake

Sunday, May 19, 2013

South Korea says N. Korea fires 3 short-range missiles

SEOUL, South Korea (AP) ? North Korea fired three short-range guided missiles into its eastern waters on Saturday, a South Korean official said. It routinely tests such missiles, but the latest launches came during a period of tentative diplomacy aimed at easing tensions.

The North fired two missiles Saturday morning and another in the afternoon, South Korean Defense Ministry spokesman Kim Min-seok said by phone. He said the North's intent was unclear. His ministry said it is watching North Korea carefully in case it conducts a provocation against South Korea.

In March, North Korea launched what appeared to be two KN-02 missiles off its east coast. Experts believe the country is trying to improve the range and accuracy of its arsenal.

North Korea recently withdrew two mid-range "Musudan" missiles believed to be capable of reaching Guam after moving them to its east coast earlier this year, U.S. officials said. The North is banned from testing ballistic missiles under U.N. Security Council resolutions.

Earlier this year, North Korea threatened nuclear strikes on Seoul and Washington because of annual U.S.-South Korean military drills and U.N. sanctions imposed over its third nuclear test in February. The drills ended late last month. This past month, the U.S. and South Korea ended another round of naval drills involving a nuclear-powered aircraft carrier off the east coast. North Korea calls such drills preparation to invade the North.

Analysts say the recent North Korean threats were partly an attempt to push Washington to agree to disarmament-for-aid talks.

This past week, Glyn Davies, the top U.S. envoy on North Korea, ended trips to South Korea, China and Japan. On Friday, an adviser to Japanese Prime Minister Shinzo Abe returned from North Korea but didn't immediately give details of his talks with officials there.

On Monday, North Korean state media showed that the country's hard-line defense minister had been replaced by a little-known army general. Outside analysts said it was part of leader Kim Jong Un's efforts to tighten his grip on the powerful military after his father Kim Jong Il died in December 2011.

The United States and Japan are participants in six-nation nuclear disarmament talks along with the Koreas, Russia and China. North Korea walked out of the talks in 2009 after the United Nations condemned it for a long-range rocket launch.

North Korea possesses an array of missiles. U.S. and South Korean officials do not believe the North's claim that it has developed nuclear warheads small enough to place on a missile. Last week in Washington, South Korean President Park Geun-hye and President Barack Obama warned North Korea against further nuclear provocations.

Tension between the two Koreas remains high after both sides pulled out their workers from a jointly run factory complex earlier this year. The countries remain technically at war after the 1950-53 Korean War ended in a truce instead of a peace treaty.

Source: http://news.yahoo.com/skorea-says-nkorea-fires-3-short-range-missiles-075933659.html

words with friends phlebotomy dog show best in show bret michaels bret michaels pekingese

Friday, May 17, 2013

A Human Stem Cell Has Been Cloned For the First Time

Almost two decades ago, scientists succeeded in cloning Dolly the sheep. Now, the same process has been allowed scientists to clone embryonic stem cells from fetal human skin cells for the very first time. There are no more barriers between us and creating human clones.

Cloning in and of itself has been within our reach for a while. Cloning non-human animals has been on the table for nearly two decades, dating back to Dolly the sheep way back in 1996. Cloning human cells has always been a bit rougher of a prospect, partly because it's just hard, and partly because experimenting with it is ground that needs to be tread very very carefully.

This breakthrough accomplishment, performed by Shoukhrat Mitalipov of Oregon Health & Science University and his colleagues, makes use of a technique called nuclear transfer. In its most basic sense, nuclear transfer is the process of taking one cell?in this case a skin cell?and inserting it into an egg cell that's had its DNA removed, which is then coaxed into dividing. Or in other words, it's sort of like fertilizing an egg cell with a fully formed cell of another sort, instead of a sperm.

This process results in a ball of stem cells that can be grown into a full-fledged clone if it's allowed to keep developing. That's how we've gotten every successful clone to date, including Dolly back in 1996. But until now, that had never worked with human cells. As documented in the journal Cell, Mitalipov and company have managed to pull off the process using skin cells of a human fetus as fertilizer, creating a whole bunch of embryonic stem cells that could go on to grow into a cloned human being. Not that anyone's planning to actually do that. Ever. These cells are for medical treatment. Stuff like treating nerve and heart damage.

Mitalipov attributes the recent success mainly to two things. First, there's the use of healthy, donated eggs?previously eggs used for experiments like this were leftovers from IVF clinics. Second, there's the slightly new approach to nuclear transfer, with several special tweaks and modifications including the infusion of caffeine at one point. The result is a reliable, high-yeild process that can create, on average, four embryonic stem cell lines from every eight eggs. Mitalipov put it this way:

We knew the history of failure, that several legitimate labs had tried but couldn't make it work. I thought we would need about 500 to 1,000 eggs to optimize the process and anticipated it would be a long study that would take several years. But in the first experiment we got a blastocyst and within a couple of months we already had an (embryonic) stem cell line. We couldn't believe it.

The implications here are huge, from both a medicinal and ethical standpoint. In the past, other scientists experimented with cloning processes that avoided ethical quandaries like extracting fetal cells, but none of those were nearly as reliable as this one. And this approach might be able to work with adult skin cells?removing fetuses from the equation?but it's still too early to tell.

And while the stem cells generated here definitely aren't intended to be used to produce actual, living, human clones, there's no reason to believe they couldn't be. And life potential like that is bound to raise all sorts of questions.

But aside from all that, this cloning process holds promise for the treatment of all kinds of degenerative diseases, though you can bet it will be a long, hard road to any sort of standardization for a whole wide variety of medical and legal reasons. Still, it's a huge step forward for science, and for young megalomaniacs who aspire to live forever through clones someday.. [Time via CNN]

Source: http://gizmodo.com/a-human-stem-cell-has-been-cloned-for-the-first-time-506916063

lindsey vonn nit first day of spring Club Penguin Espn Bracket First Day Of Spring 2013 Suki Waterhouse

Breakthrough for IVF?

Breakthrough for IVF? [ Back to EurekAlert! ] Public release date: 16-May-2013
[ | E-mail | Share Share ]

Contact: Greyling Peoples
g.peoples@elsevier.com
31-204-853-323
Elsevier

Amsterdam, May 17, 2013 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of a recent study in Reproductive BioMedicine Online on 5-day old human blastocysts showing that those with an abnormal chromosomal composition can be identified by the rate at which they have developed to blastocysts, thereby classifying the risk of genetic abnormality without a biopsy. In a new study the same group has undertaken a retrospective study, using their predictive model to assess the likelihood of any embryo transferred resulting in a successful pregnancy, with very encouraging outcomes.

One of the greatest challenges in assisted reproduction is to find the one embryo, which can develop successfully. Now, combining time lapse imaging of IVF embryos cultured for 5 days to the blastocyst stage with trophoblast biopsy, it has proved possible to correlate the rate of blastocyst formation with chromosomal abnormalities. Such an approach should allow early and widely accessible non-invasive identification of the best embryo to place in the uterus.

"Recently the world of IVF has become very excited by the use of time-lapse imaging (TLI) of early human embryo development to follow the change of embryo morphology over time", explains Martin Johnson, Editor of Reproductive BioMedicine Online. "The data can then be compared with the outcome after the embryos are transferred. The hope is that this morphokinetic analysis will enable reproductive specialists to predict more successfully those embryos most likely to generate pregnancies. The advantage of using morphokinetic analysis to predict outcome is its minimal invasiveness."

The majority of embryos that fail to initiate a pregnancy do so because they have abnormal chromosomes. Unfortunately these embryos cannot be recognized by embryologists using conventional microscopy. Only biopsy of one or a few cells of the early embryo followed by preimplantation genetic screening (PGS) can establish whether the number of chromosomes is normal or not.

In their research Alison Campbell and colleagues of CARE Fertility, Nottingham, went one step further, describing the use of morphokinetic analysis to identify those embryos that have an abnormal chromosomal constitution. In that study, they cultured embryos under time lapse imaging to day 5, by which time they formed blastocysts. These were then biopsied by removing a few of the cells from the outer layer of the embryo, which will normally contribute only to the placenta. The biopsy was then analyzed for its chromosomal constitution. The authors then related the chromosomal make up of each embryo to its morphokinetic history. They found that a proportion of embryos with chromosomal abnormalities were delayed in initiating blastocyst formation and also reached the full blastocyst stage later than did normal embryos. The authors conclude that using this approach they could avoid exposing at least a subset of the embryos to invasive biopsy procedures.

"This non-invasive model for the classification of chromosomal abnormality may be used to avoid selecting embryos with high risk of aneuploidy while selecting those with reduced risk," said lead author Alison Campbell.

The same group has now applied this risk classification model retrospectively to examine the pregnancy outcomes in a series of unselected IVF patients without the use of PGS. A significant improvement in both implantation and live birth rates was observed when low risk embryos were transferred.

Scientist Markus Montag of the Department of Gynecological Endocrinology and Fertility Disorders, University Clinics of Heidelberg, said: "The idea of using time-lapse imaging and morphokinetic analysis is intriguing, because having available a completely non-invasive procedure to predict which embryo is euploid or aneuploid would allow the application of this technique for virtually every assisted reproduction cycle. The potential benefit of such an approach is obvious in view of published data on the incidence of aneuploidy even in oocytes from younger women."

###

These research papers are:

Modelling a risk classification of aneuploidy in human embryos using non-invasive morphokinetics, by Campbell, A., Fishel, S., Bowman, N., Duffy, S., Sedler, M., Hickman, C.F.L.; Reproductive BioMedicine Online; 26, 477- 485;DOI: 10.1016/j.rbmo.2013.02.006. The article appears in Reproductive BioMedicine Online, Volume 26, Issue 5 (May 2013), published by Elsevier. Available online on ScienceDirect.

Retrospective analysis of clinical pregnancy and live birth rate for IVF embryos classified for aneuploidy risk, without PGS, demonstrates the benefit of a time-lapse imaging derived model, by Campbell, A., Fishel, S., Bowman, N., Duffy, S., Sedler, M., Thornton, S.; This article is available as an Article in Press in Reproductive Biomedicine Online (May 17, 2013), published by Elsevier. Available online on ScienceDirect on May 17.

Notes for Editors

Full text of the articles are available to journalists upon request: contact Greyling Peoples at +31 20 485 3323 or g.peoples@elsevier.com. Journalists wishing to set up interviews with the authors should contact Dr. Alison Campbell or Dr Simon Fishel.

About the authors

Alison Campbell and Simon Fishel
CARE Fertility, John Webster House, 6 Lawrence Drive, Nottingham
Business Park, Nottingham, NG8 6PZ

Alison Campbell, telephone: +44(0)161 2493040, fax: +44(0)1612244283, Alison.campbell@carefertility.com

Simon Fishel, Simon.fishel@carefertility.com

About Reproductive Biomedicine Online

Reproductive BioMedicine Online covers the formation, growth and differentiation of the human embryo. It is intended to bring to public attention new research on biological and clinical research on human reproduction and the human embryo including relevant studies on animals. It is published by a group of scientists and clinicians working in these fields of study. Its audience comprises researchers, clinicians, practitioners, academics and patients.

It is an official publication of:

The American Association of Bioanalysts (AAB) http://www.aab.org

Alpha Scientists in Reproductive Medicine, http://alphascientists.org

The American College of Embryology (ACE) http://www.embcol.org

The Global Chinese Association for Reproductive Medicine (GCARM) http://www.gcarm.com

The International Society for In Vitro Fertilization (ISIVF) http://www.isivf.com

The Mediterranean Society for Reproductive Medicine (MSRM) http://www.medreproduction.org

The Preimplantation Genetic Diagnosis International Society (PGDIS) http://www.pgdis.org

The Turkish Society of Reproductive Medicine (TSRM) http://www.tsrm.org.tr

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Breakthrough for IVF? [ Back to EurekAlert! ] Public release date: 16-May-2013
[ | E-mail | Share Share ]

Contact: Greyling Peoples
g.peoples@elsevier.com
31-204-853-323
Elsevier

Amsterdam, May 17, 2013 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of a recent study in Reproductive BioMedicine Online on 5-day old human blastocysts showing that those with an abnormal chromosomal composition can be identified by the rate at which they have developed to blastocysts, thereby classifying the risk of genetic abnormality without a biopsy. In a new study the same group has undertaken a retrospective study, using their predictive model to assess the likelihood of any embryo transferred resulting in a successful pregnancy, with very encouraging outcomes.

One of the greatest challenges in assisted reproduction is to find the one embryo, which can develop successfully. Now, combining time lapse imaging of IVF embryos cultured for 5 days to the blastocyst stage with trophoblast biopsy, it has proved possible to correlate the rate of blastocyst formation with chromosomal abnormalities. Such an approach should allow early and widely accessible non-invasive identification of the best embryo to place in the uterus.

"Recently the world of IVF has become very excited by the use of time-lapse imaging (TLI) of early human embryo development to follow the change of embryo morphology over time", explains Martin Johnson, Editor of Reproductive BioMedicine Online. "The data can then be compared with the outcome after the embryos are transferred. The hope is that this morphokinetic analysis will enable reproductive specialists to predict more successfully those embryos most likely to generate pregnancies. The advantage of using morphokinetic analysis to predict outcome is its minimal invasiveness."

The majority of embryos that fail to initiate a pregnancy do so because they have abnormal chromosomes. Unfortunately these embryos cannot be recognized by embryologists using conventional microscopy. Only biopsy of one or a few cells of the early embryo followed by preimplantation genetic screening (PGS) can establish whether the number of chromosomes is normal or not.

In their research Alison Campbell and colleagues of CARE Fertility, Nottingham, went one step further, describing the use of morphokinetic analysis to identify those embryos that have an abnormal chromosomal constitution. In that study, they cultured embryos under time lapse imaging to day 5, by which time they formed blastocysts. These were then biopsied by removing a few of the cells from the outer layer of the embryo, which will normally contribute only to the placenta. The biopsy was then analyzed for its chromosomal constitution. The authors then related the chromosomal make up of each embryo to its morphokinetic history. They found that a proportion of embryos with chromosomal abnormalities were delayed in initiating blastocyst formation and also reached the full blastocyst stage later than did normal embryos. The authors conclude that using this approach they could avoid exposing at least a subset of the embryos to invasive biopsy procedures.

"This non-invasive model for the classification of chromosomal abnormality may be used to avoid selecting embryos with high risk of aneuploidy while selecting those with reduced risk," said lead author Alison Campbell.

The same group has now applied this risk classification model retrospectively to examine the pregnancy outcomes in a series of unselected IVF patients without the use of PGS. A significant improvement in both implantation and live birth rates was observed when low risk embryos were transferred.

Scientist Markus Montag of the Department of Gynecological Endocrinology and Fertility Disorders, University Clinics of Heidelberg, said: "The idea of using time-lapse imaging and morphokinetic analysis is intriguing, because having available a completely non-invasive procedure to predict which embryo is euploid or aneuploid would allow the application of this technique for virtually every assisted reproduction cycle. The potential benefit of such an approach is obvious in view of published data on the incidence of aneuploidy even in oocytes from younger women."

###

These research papers are:

Modelling a risk classification of aneuploidy in human embryos using non-invasive morphokinetics, by Campbell, A., Fishel, S., Bowman, N., Duffy, S., Sedler, M., Hickman, C.F.L.; Reproductive BioMedicine Online; 26, 477- 485;DOI: 10.1016/j.rbmo.2013.02.006. The article appears in Reproductive BioMedicine Online, Volume 26, Issue 5 (May 2013), published by Elsevier. Available online on ScienceDirect.

Retrospective analysis of clinical pregnancy and live birth rate for IVF embryos classified for aneuploidy risk, without PGS, demonstrates the benefit of a time-lapse imaging derived model, by Campbell, A., Fishel, S., Bowman, N., Duffy, S., Sedler, M., Thornton, S.; This article is available as an Article in Press in Reproductive Biomedicine Online (May 17, 2013), published by Elsevier. Available online on ScienceDirect on May 17.

Notes for Editors

Full text of the articles are available to journalists upon request: contact Greyling Peoples at +31 20 485 3323 or g.peoples@elsevier.com. Journalists wishing to set up interviews with the authors should contact Dr. Alison Campbell or Dr Simon Fishel.

About the authors

Alison Campbell and Simon Fishel
CARE Fertility, John Webster House, 6 Lawrence Drive, Nottingham
Business Park, Nottingham, NG8 6PZ

Alison Campbell, telephone: +44(0)161 2493040, fax: +44(0)1612244283, Alison.campbell@carefertility.com

Simon Fishel, Simon.fishel@carefertility.com

About Reproductive Biomedicine Online

Reproductive BioMedicine Online covers the formation, growth and differentiation of the human embryo. It is intended to bring to public attention new research on biological and clinical research on human reproduction and the human embryo including relevant studies on animals. It is published by a group of scientists and clinicians working in these fields of study. Its audience comprises researchers, clinicians, practitioners, academics and patients.

It is an official publication of:

The American Association of Bioanalysts (AAB) http://www.aab.org

Alpha Scientists in Reproductive Medicine, http://alphascientists.org

The American College of Embryology (ACE) http://www.embcol.org

The Global Chinese Association for Reproductive Medicine (GCARM) http://www.gcarm.com

The International Society for In Vitro Fertilization (ISIVF) http://www.isivf.com

The Mediterranean Society for Reproductive Medicine (MSRM) http://www.medreproduction.org

The Preimplantation Genetic Diagnosis International Society (PGDIS) http://www.pgdis.org

The Turkish Society of Reproductive Medicine (TSRM) http://www.tsrm.org.tr

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Source: http://www.eurekalert.org/pub_releases/2013-05/e-bfi051613.php

space shuttle discovery spacex tupac hologram tupac back tax deadline death race buffet rule